MedTrace Logo

Sucrose as a Standard in Cesarean Section Surgical Wound Healing to Reduce Hospital Time

NCT06477770 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-08-23

No results posted yet for this study

Summary

It is a randomized, single-blind clinical trial, whose population to be studied will be randomized patients with a diagnosis of dehiscence and infection of a cesarean surgical wound who meet the inclusion and exclusion criteria.

H0: Sucrose does not reduce hospital days in patients with surgical wound dehiscence.

HA: Sucrose reduces hospital days in patients with surgical wound dehiscence.

Conditions

  • Surgical Wound Infection
  • Cesarean Wound; Dehiscence

Interventions

PROCEDURE

Clorhexidine soap

surgical wound will be washed with saline solution and 10 ml of chlorhexidine soap

OTHER

Sucrose

75 g of sucrose will be administered to the surgical wound at 8:00 am every day, once a day, and then it will be covered with sterile gauze.

Sponsors & Collaborators

  • Universidad Nacional Autonoma de Honduras

    lead OTHER

Principal Investigators

  • Ricardo A. Gutierrez Ramirez, MD, MSc · Universidad Nacional Autonoma de Honduras

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2024-09-30
Completion
2024-12-01

Countries

  • Honduras

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06477770 on ClinicalTrials.gov